A new migraine treatment from Pfizer is now available in US pharmacies. Reports also indicate that Pfizer has launched a cost savings program, potentially lowering drug costs for some Americans, although it is unclear how this program will affect the pricing of the new migraine treatment. Additionally, there are conflicting reports about drug price changes in the US, with some outlets suggesting price increases for certain medications.